South Korea mulls shift to preferential drug pricing system, but challenges remain | 2021-09-14

South Korea’s Ministry of Health and Welfare (MHW) is currently discussing the implementation of a preferential drug pricing system and plans to initiate an expert survey in 2022. The preferential drug pricing system is part of a three-prong strategy that South Korea plans to adopt to promote the growth of eight leading companies in the pharmaceutical, medical device and cosmetic industries by 2030.

Read the source article at BioWorld
2021-09-14 04:00:00